Avivagen Inc VIVXF

Consumer Defensive Farm Products

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.

GREY:VIVXF - Post by User

Avivagen Inc

Bullboard Posts

Post by Horn1369on Jun 03, 2016 8:56pm

252 Views

Post# 24933541

New Article today.

"Avivagen CEO Cameron Groome was sounding an upbeat tone Friday morning after his company announced it had secured $3.6 million in new funding in a private placement."

"It has the green light to sell OxC-beta to feed producers in Thailand and Taiwan and is making inroads in China, where the country’s largest food processor, COFCO Group, is collaborating with Avivagen on a trial to test the product’s effectiveness at replacing antibiotics in swine feed. Another Chinese consortium, Jintai, is partnering with Avivagen to commercialize the product there."

https://www.obj.ca/Technology/2016-06-03/article-4548778/Life-sciences-firm-Avivagen-raises-36M-in-private-placement/1

Bullboard Posts

The top 10 Canadian medical stocks